Patents for A61K 49 - Preparations for testing in vivo (35,376)
12/2011
12/29/2011WO2011097633A3 Egf receptor mimicking peptides
12/29/2011WO2011090349A3 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
12/29/2011WO2011013032A3 Method for the preparation of microparticles with efficient bioactive molecule incorporation
12/29/2011US20110321180 Compositions and methods to generate pilosebaceous units
12/29/2011US20110321179 Non-human animal model for amyotrophic lateral sclerosis (als) with loss-of-tdp-43 function
12/29/2011US20110319808 Antimicrobial composition
12/29/2011US20110318275 Multifunctional contrast agent using biocompatible polymer and preparation method
12/29/2011US20110318274 Variant of mite allergen and uses thereof
12/29/2011US20110318273 Fluorescent contrast agents
12/29/2011US20110318272 Pesticidal mixtures giving synergistic pesticidal effects
12/29/2011US20110318271 Arginase Inhibitors for the Treatment of Depression
12/29/2011US20110318270 Drug identification protocol for type 2 diabetes based on gene expression signatures
12/29/2011US20110318269 Method For Screening Phage Display Libraries Against Each Other
12/29/2011US20110318268 Herpes simplex virus (hsv) with modified tropism, uses and process of preparation thereof
12/29/2011US20110318267 Ph-responsive nanostructures
12/29/2011US20110318266 Phthalimide derivative metabotropic glutamate r4 ligands
12/29/2011US20110318265 Coupled identification and treatment of cancer
12/29/2011CA2803392A1 Dual variable domain immunoglobulins and uses thereof
12/29/2011CA2803169A1 Modeling of pharmaceutical propagation and parameter generation for injection protocols
12/28/2011EP2399612A1 Composition for labeling tissues of central nervous system, method for labeling tissues of central nervous system, and screening method using the composition for labeling tissues of central nervous system
12/28/2011EP2399610A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
12/28/2011EP2398775A1 Coupled recognition/detection system for in vivo and in vitro use
12/28/2011EP2398503A2 Gadolinium expressed lipid nanoparticles for magnetic resonance imaging
12/28/2011EP2398500A2 Glutathione-based drug delivery system
12/28/2011EP2200670B1 Bone substitute containing a contrast agent, method for preparing same and uses thereof
12/28/2011EP1667716B1 Cytotoxicity mediation of cells evidencing surface expression of cd44
12/28/2011EP1640022B1 Menthol-containing preparation
12/28/2011CN102300589A 用于帕金森氏病症的体内成像方法 Disorders in vivo imaging method for Parkinson's
12/28/2011CN102300559A 吡啶并嘧啶酮的固体口服制剂 Pyrido pyrimidinone solid oral preparations
12/28/2011CN102296072A 转导iASPP-FL癌基因在造血系统特异性高表达的小鼠模型及其制备方法和用途 Transduction iASPP-FL oncogene mouse model and preparation method of the hematopoietic system and uses specifically and highly expressed in
12/28/2011CN102295926A 一种荧光介孔氧化硅纳米材料及其制备方法和应用 A fluorescent mesoporous silica nano material and preparation method and application
12/28/2011CN102294040A 一种用于核磁共振成像和药物载体的磁性纳米聚合物囊泡及其制备方法 Magnetic nano-polymer vesicles and its preparation method for magnetic resonance imaging and drug carriers
12/28/2011CN102294039A 兼具荧光和磁性的蛋黄-蛋壳纳米胶囊的制备方法 Both fluorescent and magnetic yolk - shell nanocapsules prepared
12/28/2011CN102294038A 基于树状大分子的ct/mri双模态成像造影剂的制备 Preparation of dendrimer ct / mri bimodal imaging contrast agents based on
12/28/2011CN102294037A 废弃的<sup>99</sup>钼-<sup>99m</sup>锝发生器在脑血流图检测的应用 Abandoned <sup> 99 </ sup> Mo - <sup> 99m </ sup> Tc generator used in the detection of cerebral blood flow
12/28/2011CN102294036A 一种筛选动物抗病毒基因的方法 A method of screening method for animal antiviral gene
12/28/2011CN101511366B 在心肌显像方法期间用于增加患者耐受性的方法和组合物 During myocardial imaging method for increasing patient tolerance methods and compositions
12/27/2011US8084581 Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
12/27/2011US8084268 Method of evaluating the potential of the skin for scavenging free radicals
12/27/2011US8084056 Useful as an ultrasonic contrast agent; making by dissolving a nonaqueous solvent in a lipid blend, then contacting the solution with an aqueous solution to form a lipid suspension
12/27/2011US8084042 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines
12/27/2011US8084029 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
12/27/2011US8084028 Antibodies to VLA-1
12/27/2011US8084018 Methods for imaging dopamine transporter level
12/27/2011US8084017 In situ genetic engineering; generating image
12/27/2011US8084016 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
12/22/2011WO2011158189A1 X-ray and gamma-photon activable organic compounds, their preparation and their uses
12/22/2011WO2011088456A3 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
12/22/2011WO2010096426A8 Compounds, compositions, methods of synthesis, and methods of treatment
12/22/2011US20110313677 Method for determining the liver performance of a living organism by the means of quantitative measuring the metabolization of substrates
12/22/2011US20110311457 Methods for imaging vascular inflammation using improved nanoparticle contrast agents
12/22/2011US20110311456 Marker alloy
12/22/2011US20110311455 Encapsulated agent guided imaging and therapies
12/22/2011US20110311454 Molecules with extended half-lives, compositions and uses thereof
12/22/2011US20110311453 Alloyed semiconductor quantum dots and concentration-gradient alloyed quantum dots, series comprising the same and methods related thereto
12/22/2011US20110311452 Inflammation targeting particles
12/22/2011US20110311451 Synthesis of polymer conjugates of indolocarbazole compounds
12/22/2011US20110311450 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
12/22/2011US20110311449 Antibodies
12/22/2011US20110311448 Antibody to rage and uses for in vivo imaging or for targeting therapy
12/22/2011US20110311446 Peptides that specifically bind hgf receptor (cmet) and uses thereof
12/22/2011US20110311445 Diagnosis and treatment of myeloid and lymphoid cell cancers
12/22/2011US20110311444 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases
12/22/2011US20110311442 Direct cellular energy delivery system
12/22/2011DE102010024643A1 Contrast agent, useful for molecular ultrasound imaging, comprises a coupling substance e.g. spiegelmers bound to microbubbles
12/22/2011CA2801807A1 X-ray and gamma-photon activable organic compounds, their preparation and their uses
12/21/2011EP2396039A2 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof
12/21/2011EP1931391B1 Optical imaging of rheumatoid arthritis
12/21/2011CN1905904B 包含半胱氨酸天冬氨酸蛋白酶3抑制剂的新型显像剂 Caspase 3 inhibitor containing a novel imaging agent
12/21/2011CN102292106A Il-6抗体及其用途 Il-6 antibody and uses thereof
12/21/2011CN102286432A 建立ca16病毒感染动物模型的方法和试剂盒 Ca16 established animal models of viral infection methods and kits
12/21/2011CN102286073A 一种与牙釉质表面轴向特异性结合的七肽及其应用 One kind of enamel surface axial seven specific binding peptide and its application
12/21/2011CN102284068A 老年斑磁共振纳米诊断试剂及其优化方法 Senile plaques nano MRI diagnostic reagents and Optimization
12/21/2011CN102284067A 一类荧光分子影像探针与磁/荧光双模态分子影像探针及其制备方法 A fluorescent molecular imaging probes and magnetic / fluorescent bimodal molecular imaging probe and its preparation method
12/21/2011CN102284066A 液体石蜡作为光透明增强剂的新用途 As a new use of light liquid paraffin transparent enhancers
12/21/2011CN101565453B 具有捕获自由基功能的硝酮类化合物及其制备方法与应用 Has captured the nitrate radical function ketone compound and preparation method and application
12/20/2011US8080650 Pro104 antibody compositions and methods of use
12/20/2011US8080428 Investigation of mucosa dryness conditions
12/20/2011US8080263 Dispersion for pulmonary delivery of a bioactive agent
12/20/2011CA2447450C Corona-virus-like particles comprising functionally deleted genomes
12/15/2011WO2010118034A9 Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells
12/15/2011US20110307964 Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
12/15/2011US20110306756 Prevention and Treatment of Amyloidogenic Disease
12/15/2011US20110305641 Compositions And Methods For Treatment Of Angiogenesis-Associated Ocular Disorders
12/15/2011US20110305640 Method to treat psoriasis and other hyperproliferative skin disorders
12/15/2011US20110305639 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
12/15/2011US20110305638 Modulation of Macrophage Activation
12/15/2011US20110305636 Compounds, compositions, methods of synthesis, and methods of treatment
12/15/2011US20110305633 Methods for Treatment, the Prognostic Assessment and the Detection of Breast Cancer
12/14/2011EP2394639A1 Hyperthermic technologies and therapeutic uses thereof
12/14/2011EP1641492B1 Controlled platelet activation to monitor therapy of adp antagonists
12/14/2011CN102282153A 具有肿瘤滞留性的化合物 A compound having a tumor retention of
12/14/2011CN102281904A 染料缀合物成像剂 Dye conjugate imaging agent
12/14/2011CN102276498A 一种新的三碘苯类化合物造影剂 A new three benzene compound iodine contrast agent
12/14/2011CN102274530A 老年斑磁共振纳米诊断试剂及其制备方法 Senile plaques nano MRI diagnostic reagents and preparation method
12/14/2011CN102274529A 一种磁共振成像造影剂及其制备方法 An imaging MRI contrast agent and its preparation method
12/14/2011CN102274528A 一种对Cu<sup>2+</sup>具有选择性识别的磁共振成像造影剂 Kind of Cu <sup> 2 + </ sup> selective recognition of magnetic resonance imaging contrast agents
12/14/2011CN102274527A 供心肌灌注成像所用的对比剂 For myocardial perfusion imaging contrast agents used
12/14/2011CN102274513A ERK1/2抑制剂通过刺激巨噬细胞干扰素γ表达抑制肿瘤生长 ERK1 / 2 inhibitor by stimulating interferon-γ expression of macrophage tumor growth inhibition
12/14/2011CN101585868B 一种麒麟菜天然色素糖蛋白的提取方法及其应用 A method of extracting natural pigment Eucheuma glycoprotein and its application
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 354